Literature DB >> 25468041

Aib-containing peptide analogs: cellular uptake and utilization in oligonucleotide delivery.

Shun-ichi Wada, Tomoe Urase, Yuka Hasegawa, Kenta Ban, Aya Sudani, Yui Kawai, Junsuke Hayashi, Hidehito Urata.   

Abstract

α-Aminoisobutyric acid (Aib)-containing peptide analogs derived from TV-XIIa, a cell-penetrating peptide (CPP), were synthesized to explore structure-activity relationships. The replacement of Aib at position 1, 5, or 9 in the TV-XIIa amino acid sequence with alanine (Ala) suppressed the cellular uptake,whereas the simultaneous substitution of the two proline (Pro) residues at positions 6 and 10 with Aib(P-IV) considerably increased the cellular uptake. In order to explore the potential use of the Aib-containing peptide analogs for the cellular delivery of oligonucleotides (ODNs), we synthesized a covalent conjugate (P-IV-AON) of a 15-mer antisense ODN, which is complementary to luciferase gene, with P-IV, and the antisense effect of the P-IV-AON conjugate on luciferase expression in A549 cells was examined. Luciferase expression was decreased in the presence of the conjugate upon treatment with the reaction buffer at the concentrations of 5 and 10 μM.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25468041     DOI: 10.1016/j.bmc.2014.10.040

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Gaussian and linear deconvolution of LC-MS/MS chromatograms of the eight aminobutyric acid isomers.

Authors:  Harika Vemula; Yukiko Kitase; Navid J Ayon; Lynda Bonewald; William G Gutheil
Journal:  Anal Biochem       Date:  2016-10-19       Impact factor: 3.365

2.  Secondary structures and cell-penetrating abilities of arginine-rich peptide foldamers.

Authors:  Makoto Oba; Yu Nagano; Takuma Kato; Masakazu Tanaka
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

3.  A Novel pH-Tunable Secondary Conformation Containing Mixed Micellar System in Anticancer Treatment.

Authors:  Fu-Ying Shih; Wen-Ping Jiang; Xiaojie Lin; Sheng-Chu Kuo; Guan-Jhong Huang; Yu-Chi Hou; Chih-Shiang Chang; Yang Liu; Yi-Ting Chiang
Journal:  Cancers (Basel)       Date:  2020-02-21       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.